The publication by Kandimalla et al. demonstrates that a partial reduction in Drp1 decreases the levels of phosphorylated tau in AD and also reduces mitochondrial dysfunction, having a neuroprotective effect and enhancing synaptic activity [56]. The gene discussed is DNM1L; the disease is Alzheimer disease.